
Assisting in Quick Adaptation & Projects Upscaling through Dedicated Offshore Development Centers
-
Industry:
Healthcare -
Offerings:
Technology Services
-
Services Provided:
Requirement
The client assists pharma and diagnostics companies with forecasting disease and driving early intervention with AI-driven clinical lab test data. They wanted to outsource the development of products and processes to help them execute data analytics for this AI-based medical prediction.
Solution
Impelsys created a High-Performance Sustainable model to ensure reliable project deliveries, including providing Executive and board-level guidance. The team built a robust, secure, and HiPAA-compliant infrastructure in line with the client’s requirements.
Benefits
The hybrid development model with 80% of the workforce deployed offshore, gave a significant competitive advantage to the client through lower production costs, high-quality outputs, agile response to market needs, and sustainability.
Download the case study
Other case studies
-
Testing Healthcare
Building a Comprehensive QA COE for a Leading Cardiac Health...
Impelsys partnered with the largest US cardiac health organization to establish a QA Center of Excellence (QA COE)....
-
Testing Healthcare
Enhancing ICU Intelligence: How Our Functional Testing Enabled a Healthcare...
Impelsys provided a robust testing solution, leveraging a risk-based and requirement-mapped approach to validate ICU Connect and CritiXpert....
-
Products and Platforms Publishing
Delivering Cost Savings and Streamlined Access for a Prominent UK-Based...
Impelsys helped a leading UK-based learning and information services provider by implementing a white-labeled platform supporting eBooks and...